These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8313545)

  • 41. Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.
    Jadhav UM; Kadam NN
    J Assoc Physicians India; 2004 May; 52():370-5. PubMed ID: 15656025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease.
    Reguero JR; Cubero GI; Batalla A; Alvarez V; Hevia S; Cortina A; Coto E
    Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene-diet interaction in determining plasma lipid response to dietary intervention.
    Ordovas JM; Lopez-Miranda J; Mata P; Perez-Jimenez F; Lichtenstein AH; Schaefer EJ
    Atherosclerosis; 1995 Dec; 118 Suppl():S11-27. PubMed ID: 8821461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals.
    Gardemann A; Mages P; Katz N; Tillmanns H; Haberbosch W
    Atherosclerosis; 1999 Aug; 145(2):315-23. PubMed ID: 10488959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution and effect of apo A-IV genotype on plasma lipid and apolipoprotein levels in a Chinese population.
    Bai H; Liu R; Liu Y; Saku K; Liu BW
    Acta Cardiol; 2008 Jun; 63(3):315-22. PubMed ID: 18664021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
    Shima K; Tanaka A; Ejiri N; Maezawa H
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population.
    Cai H; Wang XL; Wilcken DE
    Atherosclerosis; 2000 Jan; 148(1):125-9. PubMed ID: 10580178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. APO B gene polymorphisms and coronary artery disease: a meta-analysis.
    Chiodini BD; Barlera S; Franzosi MG; Beceiro VL; Introna M; Tognoni G
    Atherosclerosis; 2003 Apr; 167(2):355-66. PubMed ID: 12818419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change.
    Xu CF; Boerwinkle E; Tikkanen MJ; Huttunen JK; Humphries SE; Talmud PJ
    Genet Epidemiol; 1990; 7(4):261-75. PubMed ID: 1977654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
    Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronary artery disease, lipid disorders and genetic polymorphisms.
    Ordovas JM; Schaefer EJ
    Ann Biol Clin (Paris); 1988; 46(1):24-9. PubMed ID: 2898907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography.
    Wang XL; McCredie RM; Wilcken DE
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1030-4. PubMed ID: 7627692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of apolipoprotein polymorphisms in renal transplant recipients.
    Cofan M; Cofan F; Campos B; Casals E; Zambon D; Ros E; Campistol JM; Oppenheimer F
    Transplant Proc; 2003 Aug; 35(5):1725-6. PubMed ID: 12962772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population.
    Zaiou M; Visvikis S; Gueguen R; Parra HJ; Fruchart JC; Siest G
    Clin Genet; 1994 Sep; 46(3):248-54. PubMed ID: 7820939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
    Assmann G; von Eckardstein A; Funke H
    Circulation; 1993 Apr; 87(4 Suppl):III28-34. PubMed ID: 8462178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipid parameters and apolipoprotein B RFLP studies: comparison of normal and coronary heart disease groups as defined by angiography.
    Hosking JL; Bais R; Sobecki SK; Tallis GA; Bradley J; Thomas DW
    Clin Biochem; 1992 Oct; 25(5):303-8. PubMed ID: 1362695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis.
    Duriez P; Vu Dac N; Koffigan M; Puchois P; Demarquilly C; Fievet C; Fievet P; Luyeye I; Bard JM; Fourrier JL
    Atherosclerosis; 1987 Jul; 66(1-2):153-61. PubMed ID: 3632747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease.
    Muendlein A; Saely CH; Marte T; Schmid F; Koch L; Rein P; Langer P; Aczel S; Drexel H
    Atherosclerosis; 2008 Jul; 199(1):179-86. PubMed ID: 18289550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.